All Stories

  1. Microneedles Mediated Delivery of Nanodiamonds for Quantum Sensing of Free Radicals in Skin Tissue
  2. Breaking the skin barrier: How nanoparticle-loaded microneedles are poised to redefine drug delivery
  3. Inhaled Virus-Mimicking Particles Elicit Dose-Dependent Immune Response against SARS-CoV-2 with Sex-Bias ACE2 Activity in Mice
  4. Quercetin nanoemulsion ameliorates key hallmarks of lung cancer
  5. The multiverse of zebrafish within the nanoworld
  6. Hybrid Physics-Informed and Bayesian Modeling of Single-Nanoparticle–Cell Adhesion Kinetics under Cytoskeletal Perturbation
  7. Nano-in-Micro GelMA depots assist electro-thermal-immuno orchestral treatment for solid triple negative breast tumor
  8. Co-precipitation of quercetin and lignin: unveiling phenolic fruit-derived extracts encapsulation
  9. Chemosensitizer Effects of Coencapsulation of Curcumin and Cabazitaxel in Nanostructured Lipid Carriers in Glioblastoma Cells
  10. Harnessing nature's blueprint: Unlocking the potential of subcellular structure membrane-coated nanosystems for precision medicine
  11. High drug-loaded supramolecular microgels enabled by controlled in-droplet self-assembly for adaptive treatment of inflammatory arthritis
  12. Machine Learning‐Informed Nano Co‐Assembly Inhibits Fibroblast Activation Protein and Improves Drug Delivery in Fibrotic Tissue
  13. Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease
  14. A Review of Current Computational Tools for Peptide–Protein Docking
  15. Combined M1 macrophage inhibition and thermotherapy for controlled fibroplasia and accelerated wound repair via an oxygenating ROS-responsive hydrogel
  16. Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design
  17. Nanoparticle‐Mediated Delivery of Adenosine 5′‐Monophosphate Enhances 5‐Oxoprolinase Activity to Mitigate Oxidative Stress in Heart Failure
  18. A Microneedle with Photoactive Electrospun Backing Layer Enables Multitherapy and Combined Drug Delivery to the Skin Wound
  19. Poly(lactic‐co‐glycolic acid) Nanoparticles for IL‐12 Self‐Amplifying RNA Delivery in Glioblastoma Models
  20. Identification of Subtype-Specific Vulnerabilities in Resistant Glioblastoma: A Computational Pipeline for Biomarkers and Drug Discovery
  21. Combating Gram-negative infections: The role of antimicrobial peptides and nanotechnology in overcoming antibiotic resistance
  22. A ratiometric theranostic nanoplatform with acid-triggered drug release and glutathione-activated fluorescence turn-on
  23. Design and in vitro validation of Brome mosaic –virus-like particles for gene delivery and immunomodulation of melanoma
  24. Quantum sensing of free radicals in macrophages reveals early autophagy-lysosome regulation in an atherosclerosis cell model
  25. Nanoencapsulated flavonoids for enhanced modulation of the microbiota-gut-brain axis and neurodegenerative add-on therapy
  26. PS8.2: Deciphering the Role of Amphiregulin in AEC-Derived Microvesicles: Implications for Immune Regulation and Regenerative Medicine.
  27. Granular Hydrogels as Modular Biomaterials: From Structural Design to Biological Responses
  28. Outside Front Cover
  29. Programmable Nanostructure Assembly of a Paclitaxel Derivative Enables Tunable Anticancer Therapy via Hydrogen Bond Engineering
  30. Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy
  31. Wisdom of Crowds for Supporting the Safety Evaluation of Nanomaterials
  32. Organ-on-Chip Platforms for Nanoparticle Toxicity and Efficacy Assessment: Advancing Beyond Traditional In Vitro and In Vivo Models
  33. Revolutionizing Chemotherapy Control using Black Hole Inspired Dynamics
  34. Metal-organic frameworks in sample preparation for clinical applications – A review
  35. Artificial cells and biomimicry cells: A rising star in the fight against cancer
  36. Probing Early Particle‐Cell Membrane Interactions via Single‐Cell and Single‐Particle Interaction Analysis
  37. Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens
  38. Integrated Microfluidic Chip for Neutrophil Extracellular Vesicle Analysis and Gastric Cancer Diagnosis
  39. Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
  40. Biological Augmentation Using Electrospun Constructs with Dual Growth Factor Release for Rotator Cuff Repair
  41. Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury
  42. H2O2‐Generating Advanced Nanomaterials for Cancer Treatment
  43. Engineered Shape-Tunable Copper-Coordinated Nanoparticles for Macrophage Reprogramming
  44. Local glycolysis-modulating hydrogel microspheres for a combined anti-tumor and anti-metastasis strategy through metabolic trapping strategy
  45. Reactive oxygen species switcher via MnO2-coated Prussian blue loaded hyaluronic acid methacrylate hydrogel microspheres for local anti-tumor treatment
  46. Broad-spectrum downregulation of inflammatory cytokines by polydopamine nanoparticles to protect the injured spinal cord
  47. Amniotic epithelial Cell microvesicles uptake inhibits PBMCs and Jurkat cells activation by inducing mitochondria-dependent apoptosis
  48. Effects of LinTT1-peptide conjugation on the properties of poly(ethylene glycol)-block-(ε-caprolactone) nanoparticles prepared by the nanoprecipitation method
  49. Development of Amniotic Epithelial Stem Cells Secretome-Loaded In Situ Inverse Electron Demand Diels–Alder-Cross-Linked Hydrogel as a Potential Immunomodulatory Therapeutical Tool
  50. Hybrid lipid nanoparticles derived from human mesenchymal stem cell extracellular vesicles by microfluidic sonication for collagen I mRNA delivery to human tendon progenitor stem cells
  51. Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells
  52. Hijacking plant skeletons for biomedical applications: from regenerative medicine and drug delivery to biosensing
  53. Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo (Adv. Therap. 1/2025)
  54. Tailored polysaccharide entrapping metal-organic framework for RNAi therapeutics and diagnostics in atherosclerosis
  55. Preface
  56. Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorders
  57. A Near-Infrared Light Absorbable Hydrogel with Antibacterial Effect for Mild Photothermal Regeneration of Infected Wounds
  58. Polymeric Microspheres with High Mass Fraction of Therapeutics Enabled by the Manipulation of Kinetics Factor During Emulsion Droplet Solidification
  59. A study of the oral bioavailability and biodistribution increase of Nanoencapsulation-driven Delivering radiolabeled anthocyanins
  60. Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells
  61. Interplay of nano-based delivery systems and protein signalling in ameliorating lung diseases
  62. Cyanocobalamin-loaded dissolving microneedles diminish skin inflammation in vivo
  63. Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model
  64. Electrochemical detection of atrial natriuretic peptide-coated nanocarriers based on a molecularly imprinted polymer receptor thin film
  65. Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo
  66. Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies
  67. A translational framework to DELIVER nanomedicines to the clinic
  68. Breaking barriers: The potential of nanosystems in antituberculosis therapy
  69. Next-generation chemotherapy treatments based on black hole algorithms: From cancer remission to chronic disease management
  70. Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
  71. Quantitative analysis of electroporation-mediated intracellular delivery via bioorthogonal luminescent reaction
  72. Unlocking the potential of nanomedicine: advances in precision targeting strategies
  73. Front Cover: Nano Select 7–8 / 2024
  74. Self‐Nanoformulating Poly(2‐oxazoline) and Poly(2‐oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study
  75. Antifibrotic and Pro-regenerative Effects of SMAD3 siRNA and Collagen I mRNA-Loaded Lipid Nanoparticles in Human Tenocytes
  76. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges
  77. Special Issue on Advances in Porous Materials
  78. Comparative optimization of polysaccharide-based nanoformulations for cardiac RNAi therapy
  79. Implantable Patch of Oxidized Nanofibrillated Cellulose and Lysozyme Amyloid Nanofibrils for the Regeneration of Infarcted Myocardium Tissue and Local Delivery of RNA‐Loaded Nanoparticles
  80. Lipid nanoparticles-based RNA therapies for breast cancer treatment
  81. Self-Nanoformulating Poly(2-oxazoline) and Poly(2-oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study
  82. Curcuma Longa: Nutraceutical Use and Association With Nanotechnology
  83. Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications
  84. Revolutionizing lung health: Exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases
  85. Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy
  86. In Situ Biofabrication of Microbial Cellulose Capsules Carrying Cubosomes: Toward Colon Targeted Multidrug Delivery
  87. Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis
  88. Physicochemical characterization of a lycopene‐loaded mesoporous silica nanoparticle formulation
  89. Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model
  90. Host-Directed Virus-Mimicking Particles Interacting with the ACE2 Receptor Competitively Block Coronavirus SARS-CoV-2 Entry
  91. New insights into nanomedicines for oral delivery of glucagon‐like peptide‐1 analogs
  92. Engineering and Targeting Neutrophils for Cancer Therapy
  93. Porous Silicon Nanoparticles Conjugated Magnetite‐Chitosan Graphene Oxide Nanoparticles for Effective Removal of Complex Pollutants
  94. Inside Back Cover
  95. Diatom-guided bone healing via a hybrid natural scaffold
  96. Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide
  97. Quantum Sensing of Free Radical Generation in Mitochondria of Single Heart Muscle Cells during Hypoxia and Reoxygenation
  98. Porous Si-Based Nanosystems for Immunotherapy Applications
  99. Noninvasive Novel Transdermal Drug Delivery System for Deep Drug Permeability
  100. Cell-based in vitro models for buccal permeability studies
  101. Manganese@Albumin Nanocomplex and Its Assembled Nanowire Activate TLR4‐Dependent Signaling Cascades of Macrophages
  102. Diversity-oriented combinatory formulation screen for cardiac RNAi therapeutics with polysaccharide framework
  103. Polyethylene Glycol‐Stabilized Gold Nanostars‐Loaded Microneedles for Photothermal Therapy of Melanoma
  104. Enhancing Apoptosome Assembly via Mito‐Biomimetic Lipid Nanocarrier for Cancer Therapy (Adv. Funct. Mater. 46/2023)
  105. Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases
  106. Advanced porous materials for antimicrobial treatment
  107. Evaluation of cell membrane-derived nanoparticles as therapeutic carriers for pancreatic ductal adenocarcinoma using an in vitro tumour stroma model
  108. Mycophenolic Acid-loaded Naïve Macrophage-derived Extracellular Vesicles Rescue Cardiac Myoblast after Inflammatory Injury
  109. Acid-labile chemical bonds-based nanoparticles for endosome escape and intracellular delivery
  110. Recent advances in Fenton and Fenton-like reaction mediated nanoparticle in cancer therapy
  111. Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond
  112. Development of a time-dependent oral colon delivery system of anaerobic Odoribacter splanchnicus for bacteriotherapy
  113. Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study (Adv. Funct. Mater. 34/2023)
  114. Enhancing Apoptosome Assembly via Mito‐Biomimetic Lipid Nanocarrier for Cancer Therapy
  115. Cancer Models on Chip: Paving the Way to Large‐Scale Trial Applications
  116. Development of fast dissolving polymer-based microneedles for delivery of an antigenic melanoma cell membrane
  117. Double‐Layered Polyvinylpyrrolidone–Poly(methyl vinyl ether‐alt‐maleic acid)‐Based Microneedles to Deliver Meloxicam: An In Vitro, In Vivo, and Short‐Term Stability Evaluation Study
  118. In Vitro Characterization and Real-Time Label-Free Assessment of the Interaction of Chitosan-Coated Niosomes with Intestinal Cellular Monolayers
  119. Fabricated technology of biomedical micro-nano hydrogel
  120. Multifunctional nanostructures: Intelligent design to overcome biological barriers
  121. Development of siRNA and Budesonide Dual‐Loaded Hybrid Lipid–Polymer Nanoparticles by Microfluidics Technology as a Platform for Dual Drug Delivery to Macrophages: An In Vitro Mechanistic Study
  122. Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study
  123. Injectable Nanocomposite Hydrogels of Gelatin-Hyaluronic Acid Reinforced with Hybrid Lysozyme Nanofibrils-Gold Nanoparticles for the Regeneration of Damaged Myocardium
  124. In Vitro Study of the Anti-inflammatory and Antifibrotic Activity of Tannic Acid-Coated Curcumin-Loaded Nanoparticles in Human Tenocytes
  125. Nanoparticles-based phototherapy systems for cancer treatment: Current status and clinical potential
  126. Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissues
  127. Controlled Interfacial Polymer Self‐Assembly Coordinates Ultrahigh Drug Loading and Zero‐Order Release in Particles Prepared under Continuous Flow
  128. A photoactive injectable antibacterial hydrogel to support chemo-immunotherapeutic effect of antigenic cell membrane and sorafenib by near-infrared light mediated tumor ablation
  129. Microfluidic preparation and optimization of sorafenib-loaded poly(ethylene glycol-block-caprolactone) nanoparticles for cancer therapy applications
  130. Nanostructured multifunctional stimuli-responsive glycopolypeptide-based copolymers for biomedical applications
  131. Porous Silicon Nanocarriers Boost the Immunomodulation of Mitochondria-Targeted Bovine Serum Albumins on Macrophage Polarization
  132. Recent approaches for enhancing the performance of dissolving microneedles in drug delivery applications
  133. Introduction to the RSC Advances themed collection on Nanomaterials in drug delivery
  134. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells (Adv. Healthcare Mater. 6/2023)
  135. Microfluidics as a Tool for the Synthesis of Advanced Drug Delivery Systems
  136. Fabrication of hydrogel microspheres via microfluidics using inverse electron demand Diels–Alder click chemistry-based tetrazine-norbornene for drug delivery and cell encapsulation applications
  137. Smart Nanoparticle‐based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy
  138. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells
  139. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect (Adv. Mater. 42/2022)
  140. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect
  141. Development of Surface Chemical Strategies for Synthesizing Redox‐Responsive Diatomite Nanoparticles as a Green Platform for On‐Demand Intracellular Release of an Antisense Peptide Nucleic Acid Anticancer Agent
  142. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform (Adv. Funct. Mater. 36/2022)
  143. Folic acid-mesoporous silicon nanoparticles enhance the anticancer activity of the p73-activating small molecule LEM2
  144. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform
  145. Microfluidics fabrication of micrometer‐sized hydrogels with precisely controlled geometries for biomedical applications
  146. Current trends in delivery of non-viral nucleic acid-based therapeutics for improved efficacy
  147. Autologous Skin Fibroblast‐Based PLGA Nanoparticles for Treating Multiorgan Fibrosis
  148. Molecular scale study on the interactions of biocompatible nanoparticles with macrophage membrane and blood proteins
  149. Mussel-Inspired and Bioclickable Peptide Engineered Surface to Combat Thrombosis and Infection
  150. Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform
  151. Progress in Stimuli‐Responsive Biomaterials for Treating Cardiovascular and Cerebrovascular Diseases
  152. Artificial Intelligence Deep Exploration of Influential Parameters on Physicochemical Properties of Curcumin‐Loaded Electrospun Nanofibers
  153. High drug-loaded microspheres enabled by controlled in-droplet precipitation promote functional recovery after spinal cord injury
  154. Functional biomaterials
  155. Neonatal Fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium
  156. Biomimetic platelet membrane-coated nanoparticles for targeted therapy
  157. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors (Adv. Mater. 9/2022)
  158. Surface Adsorption‐Mediated Ultrahigh Efficient Peptide Encapsulation with a Precise Ratiometric Control for Type 1 and 2 Diabetic Therapy
  159. Gelatin‐Lysozyme Nanofibrils Electrospun Patches with Improved Mechanical, Antioxidant and Bioresorbability Properties for Myocardial Regeneration Applications
  160. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors
  161. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
  162. Scaffold Vaccines for Generating Robust and Tunable Antibody Responses
  163. Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs
  164. Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells
  165. Emerging Theranostic Nanomaterials in Diabetes and Its Complications
  166. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds
  167. Inhibiting Phase Transfer of Protein Nanoparticles by Surface Camouflage–A Versatile and Efficient Protein Encapsulation Strategy
  168. In Vitro Evaluation of the Therapeutic Effects of Dual‐Drug Loaded Spermine‐Acetalated Dextran Nanoparticles Coated with Tannic Acid for Cardiac Applications
  169. Prospective Cancer Therapies Using Stimuli‐Responsive DNA Nanostructures
  170. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy (Adv. Mater. 40/2021)
  171. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy
  172. Programmable immune activating electrospun fibers for skin regeneration
  173. Nonresonant CARS Imaging of Porous and Solid Silicon Nanoparticles in Human Cells
  174. Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations
  175. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy
  176. Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery
  177. Quantitative Analysis of Porous Silicon Nanoparticles Functionalization by 1H NMR
  178. Engineering of 2D Materials To Trap And Kill SARS-CoV-2: A New Insight From Multi-Microsecond Atomistic Simulations
  179. Light‐Controlled Nanosystems: Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression (Adv. Funct. Mater. 27/2021)
  180. Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
  181. Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics
  182. Multistage signal-interactive nanoparticles improve tumor targeting through efficient nanoparticle-cell communications
  183. An organic-inorganic hybrid scaffold with honeycomb-like structures enabled by one-step self-assembly-driven electrospinning
  184. Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression
  185. A Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma
  186. Mitochondria‐Targeted Bovine Serum Albumin@Copper Sulfide Nanocomposites Conjugated with Rhodamine‐110 Dye for an Enhanced Efficacy of Cancer Photothermal Therapy
  187. Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools
  188. DNA‐Grafted Hyaluronic Acid System with Enhanced Injectability and Biostability for Photo‐Controlled Osteoarthritis Gene Therapy
  189. LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy
  190. Synthesis and therapeutic potential of stimuli-responsive metal-organic frameworks
  191. One-step microfluidics production of enzyme-loaded liposomes for the treatment of inflammatory diseases
  192. Engineered Extracellular Vesicles for Cancer Therapy
  193. Development of vaccine formulations: past, present, and future
  194. Nanoparticle‐mediated siRNA delivery systems for cancer therapy
  195. Microneedles for painless transdermal immunotherapeutic applications
  196. Anti‐Bacterial Hydrogels: A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration (Adv. Healthcare Mater. 3/2021)
  197. Intraoperative Assessment and Photothermal Ablation of the Tumor Margins Using Gold Nanoparticles
  198. Correction: Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  199. Front cover
  200. Advanced Nanosystems for Clinical Translation
  201. Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics
  202. Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  203. Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds
  204. Conventional Nanosized Drug Delivery Systems for Cancer Applications
  205. Front Matter
  206. Introduction to lignocellulosic materials
  207. Requirements and properties of biomaterials for biomedical applications
  208. Bio-Nanomedicine for Cancer Therapy
  209. Porous Silicon for Biomedical Applications
  210. Combination Therapy of Killing Diseases by Injectable Hydrogels: From Concept to Medical Applications
  211. Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique
  212. Evaluation of the effects of nanoprecipitation process parameters on the size and morphology of poly(ethylene oxide)-block-polycaprolactone nanostructures
  213. Recent progress in the design of DNA vaccines against tuberculosis
  214. Cell–Nanoparticle Interactions: Toxicity and Safety Issues
  215. A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration
  216. One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease
  217. Requirements for Animal Experiments: Problems and Challenges
  218. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines
  219. 3D scaffolding of fast photocurable polyurethane for soft tissue engineering by stereolithography: Influence of materials and geometry on growth of fibroblast cells
  220. Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines
  221. Cell Membrane Wrapping: Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions (Adv. Healthcare Mater. 17/2020)
  222. Formulation optimization and in vitro characterization of rifampicin and ceftriaxone dual drug loaded niosomes with high energy probe sonication technique
  223. Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions
  224. Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles
  225. Multifunctional 3D‐Printed Patches for Long‐Term Drug Release Therapies after Myocardial Infarction
  226. Tandem‐Mass‐Tag Based Proteomic Analysis Facilitates Analyzing Critical Factors of Porous Silicon Nanoparticles in Determining Their Biological Responses under Diseased Condition
  227. Intracellular Delivery of Budesonide and Polydopamine Co‐Loaded in Endosomolytic Poly(butyl methacrylate‐ co ‐methacrylic acid) Grafted Acetalated Dextran for Macrophage Phenotype Switch from M1 to M2
  228. The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization
  229. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery
  230. Microvascular Scaffolds: A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds (Adv. Sci. 9/2020)
  231. Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb
  232. Polyoxometalate Composites in Cancer Therapy and Diagnostics
  233. The solid progress of nanomedicine
  234. A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds
  235. Microfluidics: Microfluidics for Production of Particles: Mechanism, Methodology, and Applications (Small 9/2020)
  236. Gold–silver nanoshells promote wound healing from drug-resistant bacteria infection and enable monitoring via surface-enhanced Raman scattering imaging
  237. Recent trends on the development of systems for cancer diagnosis and treatment by microfluidic technology
  238. Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach
  239. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
  240. Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications
  241. Fabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications
  242. Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications
  243. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency
  244. Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke
  245. Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction
  246. The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties
  247. Microfibers synthesized by wet-spinning of chitin nanomaterials: mechanical, structural and cell proliferation properties
  248. New insights into ethionamide metabolism: influence of oxidized methionine on its degradation path
  249. Hybrid red blood cell membrane coated porous silicon nanoparticles functionalized with cancer antigen induce depletion of T cells
  250. Novel RET agonist for the treatment of experimental neuropathies
  251. Oral drug delivery: Overview
  252. Spray-drying for the formulation of oral drug delivery systems
  253. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery
  254. Mild temperature photothermal assisted anti-bacterial and anti-inflammatory nanosystem for synergistic treatment of post-cataract surgery endophthalmitis
  255. Superfast and controllable microfluidic inking of anti-inflammatory melanin-like nanoparticles inspired by cephalopods
  256. Gene‐Hydrogel Microenvironments: Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus (Adv. Sci. 1/2020)
  257. Osteogenic Hydrogels: Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration (Adv. Healthcare Mater. 1/2020)
  258. Cover Image
  259. Nanotechnology for Oral Drug Delivery
  260. Nanomedicine Therapies
  261. Handbook of In Vivo Chemistry in Mice
  262. Systematic in vitro biocompatibility studies of multimodal cellulose nanocrystal and lignin nanoparticles
  263. Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration
  264. Artificially cloaked viral nanovaccine for cancer immunotherapy
  265. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes
  266. Antitumor Therapeutics: A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics (Adv. Funct. Mater. 51/2019)
  267. Functionalized Bacterial Cellulose Microparticles for Drug Delivery in Biomedical Applications
  268. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting
  269. Microfluidics for Production of Particles: Mechanism, Methodology, and Applications
  270. Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus
  271. A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics
  272. Latest Advances on Bacterial Cellulose‐Based Materials for Wound Healing, Delivery Systems, and Tissue Engineering
  273. Landing a lethal blow on bacterial infections: an emerging advance of nanodots for wound healing acceleration
  274. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
  275. Antimicrobial Colloidal Silver–Lignin Particles via Ion and Solvent Exchange
  276. Metal Species–Encapsulated Mesoporous Silica Nanoparticles: Current Advancements and Latest Breakthroughs
  277. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  278. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  279. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
  280. On the issue of transparency and reproducibility in nanomedicine
  281. Self-Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  282. Acetalated Dextran Nanoparticles Loaded into an Injectable Alginate Cryogel for Combined Chemotherapy and Cancer Vaccination
  283. Microfluidics: Nuts and Bolts: Microfluidics for the Production of Biomaterials (Adv. Mater. Technol. 6/2019)
  284. Acetylated Nanocellulose for Single-Component Bioinks and Cell Proliferation on 3D-Printed Scaffolds
  285. Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
  286. Preparation and Characterization of Dentin Phosphophoryn‐Derived Peptide‐Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake
  287. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy
  288. Automatic methodologies to perform loading and release assays of anticancer drugs from mesoporous silicon nanoparticles
  289. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes
  290. Photothermal-responsive nanosized hybrid polymersome as versatile therapeutics codelivery nanovehicle for effective tumor suppression
  291. Correction to “Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles”
  292. Porous Silicon as a Platform for Radiation Theranostics Together with a Novel RIB-Based Radiolanthanoid
  293. Self‐Healing: Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration (Adv. Sci. 3/2019)
  294. Metal-Based Stents: Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases (Adv. Mater. 8/2019)
  295. Nuts and Bolts: Microfluidics for the Production of Biomaterials
  296. Laser-Activatable CuS Nanodots to Treat Multidrug-Resistant Bacteria and Release Copper Ion to Accelerate Healing of Infected Chronic Nonhealing Wounds
  297. Outer–inner dual reinforced micro/nano hierarchical scaffolds for promoting osteogenesis
  298. Advanced Nanovaccines for Immunotherapy Applications: From Concept to Animal Tests
  299. Close-loop dynamic nanohybrids on collagen-ark with in situ gelling transformation capability for biomimetic stage-specific diabetic wound healing
  300. Microfluidic mixing and devices for preparing nanoparticulate drug delivery systems
  301. Photosensitive materials for constructing on-demanded drug-release systems
  302. Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles
  303. Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases
  304. Microfluidic Nanoassembly of Bioengineered Chitosan-Modified FcRn-Targeted Porous Silicon Nanoparticles @ Hypromellose Acetate Succinate for Oral Delivery of Antidiabetic Peptides
  305. Euryale Ferox Seed-Inspired Superlubricated Nanoparticles for Treatment of Osteoarthritis
  306. Adjustable hardness of hydrogel for promoting vascularization and maintaining stemness of stem cells in skin flap regeneration
  307. Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine
  308. Cellular Internalization-Induced Aggregation of Porous Silicon Nanoparticles for Ultrasound Imaging and Protein-Mediated Protection of Stem Cells
  309. Electrospun Fibrous Architectures for Drug Delivery, Tissue Engineering and Cancer Therapy
  310. Cell‐Nanoparticle Interactions at (Sub)–Nanometer Resolution Analyzed by Electron Microscopy and Correlative Coherent Anti‐Stokes Raman Scattering
  311. Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  312. Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications
  313. pH and Reactive Oxygen Species‐Sequential Responsive Nano‐in‐Micro Composite for Targeted Therapy of Inflammatory Bowel Disease
  314. Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence
  315. GDNF mimetics delivery by porous silicon nanoparticles for improved Parkinson’s disease management
  316. DNA Hydrogel Assemblies: Bridging Synthesis Principles to Biomedical Applications
  317. Light-Activatable Assembled Nanoparticles to Improve Tumor Penetration and Eradicate Metastasis in Triple Negative Breast Cancer
  318. Impact of Pore Size and Surface Chemistry of Porous Silicon Particles and Structure of Phospholipids on Their Interactions
  319. Materials Science in Finland
  320. Production of pure drug nanocrystals and nano co-crystals by confinement methods
  321. Materials Science in Finland: (Adv. Mater. 24/2018)
  322. Engineered Multifunctional Albumin-Decorated Porous Silicon Nanoparticles for FcRn Translocation of Insulin
  323. Mesoporous Silica Nanoparticles for Targeted and Stimuli-Responsive Delivery of Chemotherapeutics: A Review
  324. Sequential Antifouling Surface for Efficient Modulation of the Nanoparticle-Cell Interactions in Protein-Rich Environments
  325. Bioengineered Porous Silicon Nanoparticles@Macrophages Cell Membrane as Composite Platforms for Rheumatoid Arthritis
  326. Electrospun Polyhydroxybutyrate/Poly(ε-caprolactone)/Sol–Gel-Derived Silica Hybrid Scaffolds with Drug Releasing Function for Bone Tissue Engineering Applications
  327. Properties and chemical modifications of lignin: Towards lignin-based nanomaterials for biomedical applications
  328. Neuroprotection: Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity (Adv. Mater. 14/2018)
  329. Immunostimulation and Immunosuppression: Nanotechnology on the Brink
  330. Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4–NKX2-5 Interaction
  331. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy
  332. The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems
  333. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines
  334. Cell Membrane-Based Nanoreactor To Mimic the Bio-Compartmentalization Strategy of a Cell
  335. Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity
  336. Gold Nanorods Conjugated Porous Silicon Nanoparticles Encapsulated in Calcium Alginate Nano Hydrogels Using Microemulsion Templates
  337. Dual-Drug Delivery Using Dextran-Functionalized Nanoparticles Targeting Cardiac Fibroblasts for Cellular Reprogramming
  338. An immunological electrospun scaffold for tumor cell killing and healthy tissue regeneration
  339. Biofunctionalized Mesoporous Silica Nanomaterials for Targeted Drug Delivery
  340. Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration
  341. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine
  342. 3D printing: prospects and challenges
  343. Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs
  344. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications
  345. Cancer Therapy: Nutlin‐3a and Cytokine Co‐loaded Spermine‐Modified Acetalated Dextran Nanoparticles for Cancer Chemo‐Immunotherapy (Adv. Funct. Mater. 42/2017)
  346. Manipulating Superparamagnetic Microparticles with an Electromagnetic Needle
  347. Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics
  348. Fabrication of Calcium Phosphate-Based Nanocomposites Incorporating DNA Origami, Gold Nanorods, and Anticancer Drugs for Biomedical Applications
  349. Nutlin-3a and Cytokine Co-loaded Spermine-Modified Acetalated Dextran Nanoparticles for Cancer Chemo-Immunotherapy
  350. Non-invasive strategies for targeting the posterior segment of eye
  351. Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
  352. Protein Coating of DNA Nanostructures for Enhanced Stability and Immunocompatibility
  353. Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling
  354. Multifunctional Nanotube-Mucoadhesive Poly(methyl vinyl ether-co -maleic acid)@Hydroxypropyl Methylcellulose Acetate Succinate Composite for Site-Specific Oral Drug Delivery
  355. Photoluminescent Hybrids of Cellulose Nanocrystals and Carbon Quantum Dots as Cytocompatible Probes for in Vitro Bioimaging
  356. Coating Nanoparticles with Plant-Produced Transferrin–Hydrophobin Fusion Protein Enhances Their Uptake in Cancer Cells
  357. A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect
  358. Surface modification of acetaminophen particles by atomic layer deposition
  359. The impact of porous silicon nanoparticles on human cytochrome P450 metabolism in human liver microsomes in vitro
  360. Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines
  361. Insights into Caco-2 cell culture structure using coherent anti-Stokes Raman scattering (CARS) microscopy
  362. A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging
  363. Microfluidic Encapsulation of Prickly Zinc-Doped Copper Oxide Nanoparticles with VD1142 Modified Spermine Acetalated Dextran for Efficient Cancer Therapy
  364. Receptor-Mediated Surface Charge Inversion Platform Based on Porous Silicon Nanoparticles for Efficient Cancer Cell Recognition and Combination Therapy
  365. Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles
  366. Nanoreactors: Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions (Adv. Mater. 11/2017)
  367. Drug Delivery: A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals (Adv. Funct. Mater. 9/2017)
  368. In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells
  369. Preparation and biological evaluation of ethionamide-mesoporous silicon nanoparticles against Mycobacterium tuberculosis
  370. Nanovaccines: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy (Adv. Mater. 7/2017)
  371. Fabrication, characterization and evaluation of bacterial cellulose-based capsule shells for oral drug delivery
  372. Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions
  373. A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals
  374. Core/Shell Nanocomposites Produced by Superfast Sequential Microfluidic Nanoprecipitation
  375. Cell Scaffolds: Electrospun Photocrosslinkable Hydrogel Fibrous Scaffolds for Rapid In Vivo Vascularized Skin Flap Regeneration (Adv. Funct. Mater. 2/2017)
  376. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy
  377. Microfluidic-assisted fabrication of carriers for controlled drug delivery
  378. Microfluidics platform for glass capillaries and its application in droplet and nanoparticle fabrication
  379. Springer Handbook of Nanotechnology
  380. Nano-Particles for Biomedical Applications
  381. Inside Cover Image, Volume 9, Issue 1
  382. Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy
  383. Quercetin-Based Modified Porous Silicon Nanoparticles for Enhanced Inhibition of Doxorubicin-Resistant Cancer Cells
  384. Drug Delivery: Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle-functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy (Adv. Mater. 46/2016)
  385. Microparticles to enhance delivery of drugs and growth factors into wound sites
  386. Active diffusion of nanoparticles of maternal origin within the embryonic brain
  387. Advances in biomedical and pharmaceutical applications of functional bacterial cellulose-based nanocomposites
  388. Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle‐functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy
  389. Enhanced Photoluminescence in Acetylene-Treated ZnO Nanorods
  390. Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells
  391. Microfluidics as a cutting-edge technique for drug delivery applications
  392. Targeted Cancer Therapy: pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin (Adv. Healthcare Mater. 15/2016)
  393. Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
  394. Antiproliferative Activity and Cellular Uptake of Evodiamine and Rutaecarpine Based on 3D Tumor Models
  395. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles
  396. Silica-Based Nanovectors: From Mother Nature to Biomedical Applications
  397. Applications of bacterial cellulose in food, cosmetics and drug delivery
  398. pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin
  399. Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model
  400. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin
  401. A comprehensive review of the neonatal Fc receptor and its application in drug delivery
  402. An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury
  403. Neovascularization: Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound (Adv. Healthcare Mater. 8/2016)
  404. Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound
  405. Functionalized nanoparticles for targeting the gastrointestinal apical membrane receptors
  406. Mesoporous Biomaterials: a Lexicon and Structured Bibliography of Reviews
  407. Chemotherapy with Porous Silicon
  408. In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
  409. Corrigendum to “Polymer-based nanoparticles for oral insulin delivery: Revisited approaches”,[Biotechnol Adv. 2015 Nov 1;33 (6 Pt 3):1342–54]
  410. Opinion Paper: Microfluidics Technique to Revolutionize the Drug Delivery Field: Current Developments and Applications
  411. Copolymers: Drug Delivery
  412. Controlled Shape and Nucleation Switching of Interfacially Polymerizable Nanoassemblies by Methyl Substitution
  413. Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure
  414. Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system
  415. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches
  416. Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells
  417. Smart Porous Silicon Nanoparticles with Polymeric Coatings for Sequential Combination Therapy
  418. Multimodal non-linear optical imaging for the investigation of drug nano-/microcrystal–cell interactions
  419. Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs
  420. Simple Microfluidic Approach to Fabricate Monodisperse Hollow Microparticles for Multidrug Delivery
  421. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation
  422. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib
  423. Diatomite nanoparticles as potential drug delivery systems
  424. Inhibition of Multidrug Resistance of Cancer Cells by Co-Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes
  425. Microfluidics: A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties (Adv. Mater. 14/2015)
  426. Multifunctional porous silicon nanoparticles for cancer theranostics
  427. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy
  428. Drug Delivery: On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications (Adv. Funct. Mater. 10/2015)
  429. A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties
  430. Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration
  431. 3.5 Current Trends and Developments for Nanotechnology in Cancer
  432. On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications
  433. Functionalization of Alkyne-Terminated Thermally Hydrocarbonized Porous Silicon Nanoparticles With Targeting Peptides and Antifouling Polymers: Effect on the Human Plasma Protein Adsorption
  434. Mesoporous Biomaterials – multifunctional materials for future medical therapies and bioanalysis
  435. Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery
  436. Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy
  437. Solid state transformations in consequence of electrospraying – A novel polymorphic form of piroxicam
  438. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers
  439. A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors
  440. Revolutionary impact of nanovaccines on immunotherapy
  441. Coherent anti-Stokes Raman scattering microscopy driving the future of loaded mesoporous silica imaging
  442. In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications
  443. Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms
  444. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium
  445. Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects
  446. Targeting Membrane Transporters and Receptors as a mean to Optimize Orally Delivered Biotechnological based Drugs through Nanoparticle Delivery Systems
  447. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart
  448. Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery
  449. Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering
  450. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers
  451. In Vivo Evaluation of Porous Silicon and Porous Silicon Solid Lipid Nanocomposites for Passive Targeting and Imaging
  452. Gene-based therapy for Type 1 diabetes mellitus: viral and nonviral vectors
  453. Fabrication of a Multifunctional Nano-in-micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix
  454. Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry
  455. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications
  456. Microfluidic Assembly of Monodisperse Multistage pH-Responsive Polymer/Porous Silicon Composites for Precisely Controlled Multi-Drug Delivery
  457. Confinement Effects on Drugs in Thermally Hydrocarbonized Porous Silicon
  458. Poly(methyl vinyl ether-alt-maleic acid)-Functionalized Porous Silicon Nanoparticles for Enhanced Stability and Cellular Internalization
  459. Mesoporous Materials and Nanocrystals for Enhancing the Dissolution Behavior of Poorly Water-soluble Drugs
  460. Microfluidic assembly of multistage porous silicon–lipid vesicles for controlled drug release
  461. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors
  462. Biocompatibility of porous silicon for biomedical applications
  463. Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake
  464. Preface
  465. Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine
  466. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy
  467. Microfluidic Templated Mesoporous Silicon–Solid Lipid Microcomposites for Sustained Drug Delivery
  468. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
  469. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
  470. Inhibition of Influenza A Virus Infection in Vitro by Saliphenylhalamide-Loaded Porous Silicon Nanoparticles
  471. Drug delivery with nanostructured porous silicon nanoparticles
  472. Nanostructured Silicon-Based Materials as a Drug Delivery System for Water-Insoluble Drugs
  473. Metabolism of the Antituberculosis Drug Ethionamide
  474. Porous Silicon Nanoparticles
  475. Evaluation of the Physicochemical and Biopharmaceutical Properties of Fluoro-Indomethacin
  476. Editorial (Hot Topic: Non-Animal Models Used in Drug Discovery: Drug Absorption and Metabolism)
  477. Improving Oral Absorption Via Drug-Loaded Nanocarriers: Absorption Mechanisms, Intestinal Models and Rational Fabrication
  478. Encyclopedia of Metalloproteins
  479. Nanostructured Porous Silicon-Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release
  480. Oral Delivery of Glucagon-like Peptide-1 and Analogs: Alternatives for Diabetes Control?
  481. A new cocrystal and salts of itraconazole: Comparison of solid-state properties, stability and dissolution behavior
  482. Nanostructured porous Si-based nanoparticles for targeted drug delivery
  483. Porous-based biomaterials for tissue engineering and drug delivery applications
  484. Amine Modification of Thermally Carbonized Porous Silicon with Silane Coupling Chemistry
  485. Toxicological Profile of Therapeutic Nanodelivery Systems
  486. Nanostructured porous silicon materials: potential candidates for improving drug delivery
  487. Nanostructured porous silicon in preclinical imaging: Moving from bench to bedside
  488. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles
  489. The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems
  490. Intravenous Delivery of Hydrophobin-Functionalized Porous Silicon Nanoparticles: Stability, Plasma Protein Adsorption and Biodistribution
  491. Nanoparticulate targeted drug delivery using peptides and proteins
  492. Cellular interactions of surface modified nanoporous silicon particles
  493. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles
  494. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles
  495. 18F-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography
  496. Editorial [Hot Topic: Innovative Technologies for Drug Delivery Applications: From Biopolymers and Nanocapsules to Inorganic Materials (Guest Editor: Helder A. Santos)]
  497. Multifunctional Porous Silicon for Therapeutic Drug Delivery and Imaging
  498. 4th BBBB International Conference on Pharmaceutical Sciences
  499. Poster Presentation
  500. Drug Delivery Formulations of Ordered and Nonordered Mesoporous Silica: Comparison of Three Drug Loading Methods
  501. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole
  502. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles
  503. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
  504. Mesoporous materials as controlled drug delivery formulations
  505. In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size
  506. Long time effect on the stability of silver nanoparticles in aqueous medium: Effect of the synthesis and storage conditions
  507. Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats
  508. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells
  509. Electrochemical Properties of Phospholipid Monolayers at Liquid–Liquid Interfaces
  510. Biocompatibility of mesoporous silicon microparticles
  511. Drug dissolution studies on mesoporous silicon particles—A theoretical approach
  512. Failure of MTT as a Toxicity Testing Agent for Mesoporous Silicon Microparticles
  513. Thermodynamic analysis of binding between drugs and glycosaminoglycans by isothermal titration calorimetry and fluorescence spectroscopy
  514. Adsorption–Penetration Studies of Glucose Oxidase into Phospholipid Monolayers at the 1,2-Dichloroethane/Water Interface
  515. Cover Picture: Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface (ChemPhysChem 6/2007)
  516. Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface
  517. Analysis of adsorption of phospholipids at the 1,2-dichloroethane/water interface by electrochemical impedance spectroscopy: A study of the effect of the saturated alkyl chain
  518. Preparation of nanostructures composed of dextran sulfate/ruthenium nanoparticles and their interaction with phospholipid monolayers at a liquid–liquid interface
  519. Electrochemical Study of Interfacial Composite Nanostructures:  Polyelectrolyte/Gold Nanoparticle Multilayers Assembled on Phospholipid/Dextran Sulfate Monolayers at a Liquid−Liquid Interface
  520. Interfacial Interaction between Dextran Sulfate and Lipid Monolayers:  An Electrochemical Study†
  521. CHAPTER 9. Diatoms: A Natural Source of Nanostructured Silica for Drug Delivery